Inlyta
Inlyta Inlyta is the branded formulation of the multitargeted tyrosine‑kinase inhibitor cabozantinib. It is indicated primarily for the treatment of advanced or metastatic renal cell carcinoma (RCC) and hepatocellular carcinoma…
Injectafer
Injectafer Injectafer is an intravenously administered iron formulation used in the management of iron‑deficiency states. It is preferred when rapid iron repletion is required or when patients cannot tolerate oral…
Ingrezza
Ingrezza Vortioxetine Hydrochloride – a multimodal antidepressant approved for the treatment of Major Depressive Disorder (MDD) in adults. Mechanism of Action Serotonin (5‑HT) reuptake inhibition (SERT inhibition) → ↑ synaptic…
Inflectra
Inflectra Inflectra (generic name infliximab biosimilar) is a chimeric monoclonal antibody that mimics the reference drug infliximab. It competitively binds to tumor necrosis factor‑α (TNF‑α), inhibiting downstream inflammatory signaling. Approved…
Infed
I’m not aware of a marketed drug or approved medication named “Infed.” It’s possible that the name refers to a proprietary IV formulation, a niche veterinary product, or a brand…
Indomethacin
Indomethacin --- Mechanism of Action The INDOMETHACIN is a non‑steroidal anti‑inflammatory drug (NSAID) that exerts its therapeutic effects through inhibition of cyclooxygenase (COX) enzymes. COX‑1 & COX‑2 inhibition: preferentially blocks…
Inderal
Inderal Inderal (propranolol) is a non‑selective beta‑adrenergic blocker widely used for cardiovascular conditions, migraine prophylaxis, and other indications. Mechanism of Action Competitive antagonist of β₁‑ and β₂‑adrenergic receptors ↓ Sympathetic…
Indapamide
Indapamide Indapamide is a thiazide‑like diuretic commonly prescribed for hypertension, heart failure, and edema management. Mechanism of Action Inhibits the Na⁺/Cl⁻ symporter in the distal convoluted tubule (DCT), reducing sodium…
Incruse Ellipta
Incruse Ellipta Mechanism of Action Incruse Ellipta contains tiotropium bromide, a long‑acting inhaled anticholinergic bronchodilator. Selective M₃ muscarinic receptor antagonist → blocks acetylcholine‑mediated bronchoconstriction. Prolonged action due to slow dissociation…
Inbrija
Inbrija Abecma – Autologous CD19‑Directed CAR‑T Cell Therapy --- Mechanism of Action Inbrija is a autologous chimeric antigen receptor T (CAR‑T) cell therapy that targets the CD19 antigen expressed on B‑cell…